FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related ...

Retrieved on: 2024-10-23 15:14:56

Tags for this article:

Click the tags to see associated articles and topics

FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related .... View article details on hiswai:

Excerpt

... medical device application for DrugSorb™-ATR and initiated substantive review. ... technology to CytoSorb, to reduce the severity of ...

Article found on: www.biospace.com